Drug Wholesaler McKesson to Pay $190 Million

Drug wholesaler McKesson Corp. agreed to pay the United States approximately $190 million to resolve claims that it violated the False Claims Act by reporting inflated pricing information for a large number of prescription drugs, causing Medicaid to pay too much, the Department of Justice said April 26.

DOJ said the government alleges San Francisco-based McKesson reported the inflated pricing data to First DataBank (FDB), a publisher of drug prices that are used by most state Medicaid programs to set payment rates for pharmaceuticals. The settlement is based on the United States allegations that McKesson reported inflated markup percentages to ...